Burden and Determinants of Emerging and Re-emerging Fungal Pathogens: Resistance to Antifungal Drugs, Mechanisms, and Future Mitigation Strategies

Emerging and re-emerging human fungal pathogens are becoming more closely associated, with 13,000,000 morbidity and 1500000 mortality incidences per year. Human fungal pathogens are mainly found in critically ill and immunocompromised patients. Climate change, agricultural activities, occupational hazards, deforestation, migratory trends of people, clay dispersion, decreased immunity of patients, biofilm development, medication tolerance, and resistance to antifungal therapies are all factors that contribute to the emergence of fungaldiseases. This document makes recommendations for those who set policy, general population health experts, and other respective bodies to improve the laboratory infrastructure and monitoring, promote innovative and affordable investigations, and execute public health programmes to combat these fungal infections, including preventing the emergence of antifungal medication resistance. How to cite this article: Girma A. Burden and Determinants of Emergingand Re-emerging Fungal Pathogens: Resistance to Antifungal Drugs, Mechanisms, and Future Mitigation Strategies. J Commun Dis. 2023;55(4):86-96. DOI: https://doi.org/10.24321/0019.5138.202360